U.S. Industrials Stock News

NYSE:FNF
NYSE:FNFInsurance

Fidelity National Financial (FNF) Trades Below Fair Value, Is A 17% Undervalued View Convincing?

Recent Share Price Moves For Fidelity National Financial Stock Fidelity National Financial (FNF) has drawn investor attention after recent share price moves, with the stock closing at US$51.59. Returns over the past month and past 3 months show mixed short term performance. For investors tracking Fidelity National Financial, short horizon returns can provide context for how the stock has traded around broader market moves, but they rarely tell the full story on their own. See our latest...
NYSE:VSXY
NYSE:VSXYSpecialty Retail

SpaceX Stock Volatility Puts Downside Protection Tools In Focus

SpaceX’s steep share price fall, heavy short selling and the pressure around its first earnings report have pushed downside protection and hedging tools into the spotlight. When a company with more than $500b in market cap wiped off experiences this kind of volatility, investors often look beyond the headline stock and toward products that can help manage risk or express a cautious view. This article walks through 3 stocks from a Short Sellers and Downside Protection Strategies screener that...
NYSE:TDY
NYSE:TDYElectronic

What Teledyne Technologies (TDY)'s Earnings Beat and ESOP Shift Means For Shareholders

In the second quarter of 2026, Teledyne Technologies reported higher sales of US$1,662.5 million and net income of US$251.7 million year over year, while also completing a US$399.98 million share repurchase program and filing a US$651.22 million shelf registration for 1,000,000 ESOP-related common shares. The combination of stronger earnings and the shift from buybacks to an employee stock ownership plan framework highlights management’s focus on reinforcing both profitability and long-term...
NYSE:BKU
NYSE:BKUBanks

Did Higher NII, Lower Charge-offs, and Buybacks Just Shift BankUnited's (BKU) Investment Narrative?

BankUnited, Inc. reported second-quarter 2026 results showing net interest income of US$255.33 million and net income of US$70.66 million, both modestly higher than a year earlier, with diluted EPS from continuing operations rising to US$0.97. Alongside this earnings improvement, the bank’s net charge-offs roughly halved to US$6.37 million and it completed a US$154.18 million buyback retiring 4.68% of its shares, underscoring management’s focus on credit quality and capital returns. We’ll...
NYSE:LUV
NYSE:LUVAirlines

US Travel Stocks Back In Focus As Lower Oil Reshapes Airline And Freight Outlook

Geopolitics, oil prices and interest rate expectations just collided in a way that puts US airlines and travel stocks back in focus. President Trump’s decision to cancel planned strikes on Iran eased conflict risks, helped pull oil sharply lower and coincided with a strong move in the Dow, S&P 500 and Nasdaq. That mix can quickly reshape expectations for fuel costs, demand and risk appetite. This article walks through 3 US airlines and travel stocks exposed to this news, explaining why some...
NYSE:ETN
NYSE:ETNElectrical

Eaton (ETN) Jumps On Q2 Sales Growth And New Guidance As Valuation Debate Heats Up

Eaton (ETN) stock is in focus after the company reported second quarter 2026 results with higher sales but lower net income year over year, along with new earnings guidance for the third quarter and full year. See our latest analysis for Eaton. Eaton shares traded at about $415.20 after the results, with a 1-day share price return of 7.32% and a year-to-date share price return of 26.85%. The 5-year total shareholder return of 176.02% points to strong longer term compounding, even though the...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Is 10x Genomics (TXG) Fully Valued Following Its Lausanne Cancer Diagnostics Collaboration?

10x Genomics (TXG) stock is in focus after the company announced a multi year research collaboration with Lausanne University Hospital to study cancer diagnostics using its single cell and spatial platforms. See our latest analysis for 10x Genomics. The Lausanne collaboration lands at a moment when 10x Genomics has been in sharp focus, with the share price at US$47.27 and a 30 day share price return of 21.05% feeding into a 90 day share price return of 110.74% and a 1 year total shareholder...
NasdaqGS:FRME
NasdaqGS:FRMEBanks

How Rising Net Interest Income but Lower Earnings May Shape First Merchants’ (FRME) Profitability Trajectory

In July 2026, First Merchants Corporation reported second-quarter and first-half results showing higher net interest income, with US$158.94 million for the quarter and US$310.24 million for the six months, compared with the prior year. Despite this revenue-related improvement, net income and earnings per share from continuing operations fell for both periods, highlighting pressure on overall profitability even as the bank’s core lending engine expanded. We’ll now examine how this mix of...
NasdaqGM:SYM
NasdaqGM:SYMMachinery

August 2026's Top 3 Stocks Estimated To Trade Below Fair Value

Over the last 7 days, the United States market has remained flat, yet it is up 18% over the past year with earnings projected to grow by 16% annually in the coming years. In this environment, identifying stocks that are trading below their fair value can present opportunities for investors looking to capitalize on potential growth while minimizing risk.
NasdaqGS:VCTR
NasdaqGS:VCTRCapital Markets

3 Growth Stocks With High Insider Ownership To Watch Now

Over the last 7 days, the United States market has remained flat, yet it has experienced an impressive 18% rise over the past year, with earnings forecasted to grow by 16% annually. In such a climate, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.
OTCPK:TSPH
OTCPK:TSPHTransportation

3 Penny Stocks With Market Caps Larger Than $40M To Watch

The market remained flat over the last week, yet it is up 18% over the past year, with earnings forecast to grow by 16% annually. Investing in penny stocks—often smaller or newer companies—can still open doors to growth opportunities, particularly when these stocks are backed by strong financial health. This article explores several penny stocks that offer compelling opportunities with less risk than one might expect, showcasing above-average balance sheet resilience.
NYSE:OHI
NYSE:OHIHealth Care REITs

Best Dividend Stocks For August 2026

The United States market remained flat over the last week, but it has risen 18% over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying strong dividend stocks can be an effective strategy for investors seeking stable income and potential capital appreciation.
NYSE:AMN
NYSE:AMNHealthcare

3 US Defensive Stocks Built For Inflation And Rate Uncertainty

With inflation still running above the Fed’s 2% target and rate expectations shifting with every new comment from policymakers, many investors are rethinking how to position their portfolios. Defensive sector stocks can sometimes offer a steadier ride when interest rates and bond yields are in focus, because these companies sell essential goods and services that people tend to keep buying. This article looks at three U.S. defensive stocks that are closely exposed to the latest Federal Reserve...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Newell Brands (NWL) Beat Expectations, Is The Stock Now Fully Priced?

Newell Brands (NWL) has just paired stronger second quarter earnings with a higher full year sales growth outlook and a new US$800 million asset based revolving credit facility, drawing fresh attention to the stock. See our latest analysis for Newell Brands. The latest earnings beat, higher sales outlook and new US$800 million credit facility appear to have shifted sentiment toward Newell Brands, with a 1-day share price return of 8.95% and a year-to-date share price return of 50.54%...
NYSE:BH.A
NYSE:BH.AHospitality

Is Biglari Holdings (BH.A) Undervalued After Its Recent Rally?

Biglari Holdings stock performance snapshot Biglari Holdings (BH.A) has drawn investor attention after recent share price moves, with the stock last closing at US$1,984.54. Returns show mixed short term performance, with a decline over the past month but gains over the past 3 months. See our latest analysis for Biglari Holdings. For context, Biglari Holdings has seen its share price pull back over the past month, even after a strong 3 month share price return of 28.42% and a 1 year total...
NYSE:BFH
NYSE:BFHConsumer Finance

How Bread Financial’s Q2 2026 Capital Return Moves May Impact Bread Financial Holdings (BFH) Investors

Bread Financial Holdings, Inc. reported second-quarter 2026 results with net interest income of US$1,039 million and net income of US$146 million, while also completing a buyback of 7,343,098 shares for US$551.36 million and declaring a quarterly dividend of US$0.23 per share payable on September 15, 2026. The combination of higher earnings per share, a large completed repurchase that reduced the share count, and continued cash returns through dividends underscores management’s ongoing focus...
NasdaqGS:PI
NasdaqGS:PISemiconductor

3 US Stocks Built For Tariff Driven Supply Chain Shifts

The latest round of Section 301 and Section 338 tariffs is prompting investors to reconsider how exposed portfolios are to complex global supply chains. Higher duties, extra compliance checks and uncertain trade rules can all squeeze margins or re-route production closer to home. That is where a curated US manufacturing and onshoring screener can help focus attention. It filters for larger, financially healthy companies with operations rooted in North America. In this article, you will see...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

The Bull Case For TriMas (TRS) Could Change Following Upbeat Guidance And Capital Return Push - Learn Why

TriMas Corporation’s recent second-quarter and six-month 2026 results showed slightly higher sales of US$174.58 million and US$342.86 million respectively, alongside lower quarterly net income of US$13.37 million but a very large six‑month net income of US$814.2 million, while continuing its share repurchase program and affirming a US$0.0400 quarterly dividend. Beneath the headline numbers, the combination of improved profitability from continuing operations, a long-running buyback that has...
NYSE:JXN
NYSE:JXNDiversified Financial

Is Jackson Financial (JXN) Below Fair Value On Its CEO And CFO Transition?

Jackson Financial (JXN) is entering a planned leadership transition that will place longtime finance executive Don W. Cummings in the Chief Executive Officer role and elevate Brian M. Walta to Chief Financial Officer. See our latest analysis for Jackson Financial. Jackson Financial’s leadership reshuffle arrives during a period of strong stock momentum, with a 30 day share price return of 16.98%, year to date share price return of 13.79%, and a 1 year total shareholder return of 50.40%,...
NYSE:TFX
NYSE:TFXMedical Equipment

How FDA Approval of First Freeze Dried Plasma Platform Will Impact Teleflex (TFX) Investors

Teleflex Incorporated recently received U.S. FDA Biologics License Application approval for EZPLAZ Freeze Dried Plasma, the first FDA-licensed freeze dried plasma for adult transfusions when conventional plasma products are unavailable. This approval gives Teleflex its first biologics license for a blood component and introduces a patented flexible bag format that addresses battlefield and prehospital trauma care logistics. We’ll now examine how this first-of-its-kind FDA-approved freeze...
NasdaqGS:CFFN
NasdaqGS:CFFNBanks

What Capitol Federal Financial (CFFN)'s Strong Q3 Results and Completed Buyback Mean For Shareholders

Capitol Federal Financial, Inc. recently reported third-quarter 2026 results, including US$53.48 million in net interest income, US$23.57 million in net income, minimal net charge-offs of US$148,000, completion of a 9,976,478-share buyback totaling US$72.84 million, and reaffirmed a US$0.085 quarterly dividend per share. Together, higher net interest income, growing net income and the completed share repurchase program underscore management’s clear emphasis on capital return and operating...
NasdaqGS:MCBS
NasdaqGS:MCBSBanks

MetroCity Bankshares (MCBS) Earnings Drew Interest, Is The Stock Still Cheap?

MetroCity Bankshares earnings trigger fresh interest MetroCity Bankshares (MCBS) has drawn investor attention after reporting second quarter 2026 results, with net interest income of $44.04 million and net income of $22.13 million, both higher than the prior year period. See our latest analysis for MetroCity Bankshares. MetroCity Bankshares has seen mixed trading around the earnings release, with the share price slipping 4.09% over the past month but still posting a 34.68% year to date share...
NasdaqGS:BUSE
NasdaqGS:BUSEBanks

First Busey (BUSE) Earnings Jumped And Buybacks Ended, Is The Stock Fairly Valued?

Why First Busey’s latest earnings and buyback matter for investors First Busey (BUSE) has drawn fresh attention after second quarter and year to date results showed much higher net income and earnings per share, alongside the completion of a multi year share repurchase program. See our latest analysis for First Busey. At a share price of $30.86, First Busey has delivered a 15.97% 90 day share price return and a 45.10% 1 year total shareholder return, which indicates that recent earnings and...
NasdaqGM:ETON
NasdaqGM:ETONPharmaceuticals

Eton Pharmaceuticals (ETON) Files For Pediatric Label Expansion, Is The Stock Fully Priced?

Eton Pharmaceuticals (ETON) has filed a Prior Approval Supplement with the U.S. Food and Drug Administration to expand KHINDIVI’s label to younger pediatric patients, following bioequivalence data versus ALKINDI SPRINKLE hydrocortisone granules. See our latest analysis for Eton Pharmaceuticals. The KHINDIVI label expansion filing comes after a very strong run in Eton Pharmaceuticals’ stock, with a 30 day share price return of 26.73%, a 90 day share price return of 60.62% and a year to date...